Frontlight ResearchEarly access
Trial site
START Mountain Region, LLC
- 6running trials
- 1closed trial
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer4 trials
- Lung cancer4 trials
- Endometrial cancer3 trials
- Gastric and oesophageal cancer3 trials
- Mesothelioma2 trials
- Ovarian cancer2 trials
- Pancreatic cancer2 trials
- Prostate cancer2 trials
- Bladder cancer1 trial
- Head and neck cancer1 trial
- Metastatic breast cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 16 trials
- Phase 1/21 trial
- Status
- Recruiting5 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- IDEAYA Biosciences3 trials
- Cogent Biosciences, Inc.1 trial
- Coherus Oncology, Inc.1 trial
- Gilead Sciences1 trial
- Seagen, a wholly owned subsidiary of Pfizer1 trial
Running trials
Not yet recruiting
Recruiting
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Recruiting
Recruiting
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Recruiting
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer3 recruiting
- Endometrial cancer3 recruiting
- Gastric and oesophageal cancer3 recruiting
- Lung cancer3 recruiting
- Prostate cancer2 recruiting
- Bladder cancer1 recruiting
- Head and neck cancer1 recruiting
- Mesothelioma1 recruiting
- Metastatic breast cancer1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026